Akebia Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Akebia Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Akebia Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $9.3M, a 30.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $9.3M -$4.11M -30.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $10.4M -$4.03M -28% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.4M -$16.6M -59.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $12.4M -$16.7M -57.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $13.4M -$16.9M -55.8% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $14.4M -$17.1M -54.3% Jun 30, 2023 10-Q 2023-08-28
Q1 2023 $28M -$4.67M -14.3% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $29.2M -$4.69M -13.9% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $30.3M +$7.15M +30.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $31.5M +$7.05M +28.9% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $32.6M +$6.96M +27.1% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $33.9M +$6.98M +26% Dec 31, 2021 10-K/A 2023-08-28
Q3 2021 $23.2M -$2.53M -9.83% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $24.4M -$2.44M -9.08% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $25.7M -$2.36M -8.41% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $26.9M -$2.16M -7.45% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $25.7M -$4.42M -14.7% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $26.9M -$4.34M -13.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $28M -$4.37M -13.5% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $29M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $30.1M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $31.2M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $32.4M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.